Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ptc Therapeutics (PTCT) Amortization - Intangibles: 2017-2024

Historic Amortization - Intangibles for Ptc Therapeutics (PTCT) over the last 8 years, with Dec 2024 value amounting to $60.7 million.

  • Ptc Therapeutics' Amortization - Intangibles rose 148.16% to $7.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $18.7 million, marking a year-over-year decrease of 86.11%. This contributed to the annual value of $60.7 million for FY2024, which is 72.72% down from last year.
  • According to the latest figures from FY2024, Ptc Therapeutics' Amortization - Intangibles is $60.7 million, which was down 72.72% from $222.6 million recorded in FY2023.
  • Ptc Therapeutics' Amortization - Intangibles' 5-year high stood at $222.6 million during FY2023, with a 5-year trough of $36.9 million in FY2020.
  • For the 3-year period, Ptc Therapeutics' Amortization - Intangibles averaged around $133.3 million, with its median value being $116.6 million (2022).
  • Its Amortization - Intangibles has fluctuated over the past 5 years, first spiked by 112.77% in 2022, then crashed by 72.72% in 2024.
  • Yearly analysis of 5 years shows Ptc Therapeutics' Amortization - Intangibles stood at $36.9 million in 2020, then soared by 48.51% to $54.8 million in 2021, then skyrocketed by 112.77% to $116.6 million in 2022, then skyrocketed by 90.94% to $222.6 million in 2023, then crashed by 72.72% to $60.7 million in 2024.